NCT04518215

Brief Summary

Upper abdominal surgeries are associated with severe postoperative pain. Thus, maintaining effective postoperative analgesia in the paediatric age group is very crucial in terms of future pain perception and chronic pain development. Erector Spinae Plane Block (ESPB) is an interfascial plane block characterized by its ease of application and low complication rates with the introduction of ultrasonography. The aim of this study is to investigate the analgesic effects of ESPB in this particular age-group.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Aug 2020

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 15, 2020

Completed
4 days until next milestone

First Posted

Study publicly available on registry

August 19, 2020

Completed
1 day until next milestone

Study Start

First participant enrolled

August 20, 2020

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 15, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 15, 2022

Completed
Last Updated

February 9, 2023

Status Verified

February 1, 2023

Enrollment Period

2.3 years

First QC Date

August 15, 2020

Last Update Submit

February 7, 2023

Conditions

Keywords

Erector spinae plain blockUltrasound-guidedPaediatricUpper abdominal surgeryAnalgesiaAnesthesia

Outcome Measures

Primary Outcomes (1)

  • Tramadol consumption.

    Total dose of Tramadol (measured in mg) given intra-venously to the patient post-operatively.

    24 hours

Study Arms (2)

ESPB group

EXPERIMENTAL

Erector Spinae Plain Block

Procedure: Erector Spinae Plain BlockProcedure: Intra-Venous Analgesia

IV Analgesia group

ACTIVE COMPARATOR

Intra-Venous Analgesia

Procedure: Intra-Venous Analgesia

Interventions

Patients will receive erector spinae plane block (ESP) at the level of T 9-10. Following skin sterilization, high-frequency linear ultrasound probe will be placed 1-2 cm lateral to the midline at the T 9 level. After identification of the erector spinae muscle (ESM) and the transverse process; a 22 G needle will be inserted, in a cranio-caudal direction, deep into the ESM in an in-plane technique. Correct needle placement will be verified with the administration of 0.5-1 ml Normal Saline to view the hydrodissection between the transverse process and the ESM. 0.25% Bupivacaine in a calculated volume of 0.5 ml/kg (with a maximum dose of 20 ml) will be injected deep to the erector spinae muscle for unilateral ESPB.

ESPB group

Post-operative rescue analgesic plan will consist of 15 mg/kg Paracetamol IV if the FLACC \[Face, Leg, Activity, Cry, Consolability\] score is 2-4 and 1 mg/kg Tramadol IV if FLACC score \> 4.

ESPB groupIV Analgesia group

Eligibility Criteria

Age2 Years - 12 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • ASA I - II.
  • Elective open upper abdominal surgeries, e.g., open cholecystectomy, splenectomy, pyeloplasty, renal cysts excision, partial or total nephrectomy.

You may not qualify if:

  • Patient's next of kin refusal.
  • Allergy to local anaesthetics.
  • Infection at the site of injection.
  • Coagulopathy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cairo University Hospitals

Cairo, Egypt

Location

MeSH Terms

Conditions

Agnosia

Condition Hierarchy (Ancestors)

Perceptual DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Atef K Salama, MD

    Kasr Al-Ainy Hospital, Faculty of Medicine, Cairo University

    PRINCIPAL INVESTIGATOR
  • Nazmy S Michael, MD

    Kasr Al-Ainy Hospital, Faculty of Medicine, Cairo University

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Clinical Professor

Study Record Dates

First Submitted

August 15, 2020

First Posted

August 19, 2020

Study Start

August 20, 2020

Primary Completion

December 15, 2022

Study Completion

December 15, 2022

Last Updated

February 9, 2023

Record last verified: 2023-02

Locations